A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma
NCT07436221
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
AK139
DRUG:
AK139
DRUG:
AK139
DRUG:
Placebo
Sponsor
Akeso